当前位置:首页 - 行情中心 - 东方生物(688298) - 财务分析 - 现金流量表

东方生物

(688298)

  

流通市值:39.07亿  总市值:39.07亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金501,200,438.12277,921,807.02987,470,919.91686,034,931.2
  收到的税费返还25,505,202.7115,216,296.1241,852,899.0433,046,574.52
  收到其他与经营活动有关的现金82,939,391.240,016,546.0248,969,681.1272,722,726.25
  经营活动现金流入小计609,645,032.03333,154,649.161,078,293,500.07791,804,231.97
  购买商品、接受劳务支付的现金226,654,698.77120,192,921.96389,575,168.46327,921,176.02
  支付给职工以及为职工支付的现金250,468,005.95136,828,467.85517,655,491.53356,587,056.88
  支付的各项税费22,579,492.6317,015,589.4336,374,980.8934,469,429.64
  支付其他与经营活动有关的现金153,108,959.7388,226,426.12328,586,907.75227,459,359.26
  经营活动现金流出小计652,811,157.08362,263,405.361,272,192,548.63946,437,021.8
  经营活动产生的现金流量净额-43,166,125.05-29,108,756.2-193,899,048.56-154,632,789.83
二、投资活动产生的现金流量:
  收回投资收到的现金314,437,600202,390,502.41466,088,560.25500,694,127.14
  取得投资收益收到的现金2,495,825.38443,327.749,285,727.171,665,124.38
  处置固定资产、无形资产和其他长期资产收回的现金净额171,161.64,1052,615,756.22313,562.45
  收到的其他与投资活动有关的现金80,559,378.879,989,111.181,625,094,230.213,778,942,720.64
  投资活动现金流入小计397,663,965.78282,827,046.332,103,084,273.854,281,615,534.61
  购建固定资产、无形资产和其他长期资产支付的现金187,233,055.15132,827,020.28307,667,970.63269,792,868.01
  投资支付的现金341,002,350.04245,826,933.25416,553,139.64334,307,881.48
  取得子公司及其他营业单位支付的现金00--
  支付其他与投资活动有关的现金889,241,200.37622,547,038.52801,262,146.683,991,221,500.92
  投资活动现金流出小计1,417,476,605.561,001,200,992.051,525,483,256.954,595,322,250.41
  投资活动产生的现金流量净额-1,019,812,639.78-718,373,945.72577,601,016.9-313,706,715.8
三、筹资活动产生的现金流量:
  吸收投资收到的现金186,000186,0000-
  其中:子公司吸收少数股东投资收到的现金186,000186,000--
  取得借款收到的现金221,460,708.364,117,005.3384,000,000346,000,000
  收到其他与筹资活动有关的现金30,490,201.7528,492,298.6902,281,234.1
  筹资活动现金流入小计252,136,910.0592,795,303.99384,000,000348,281,234.1
  偿还债务支付的现金95,797,012.3661,000,000510,060,000500,000,000
  分配股利、利润或偿付利息支付的现金2,960,766.21,272,700.8341,117,451.25,600,403.21
  其中:子公司支付给少数股东的股利、利润0-34,405,757.37-
  支付其他与筹资活动有关的现金6,874,254.652,585,593.3466,704,007.4963,394,252.79
  筹资活动现金流出小计105,632,033.2164,858,294.17617,881,458.69568,994,656
  筹资活动产生的现金流量净额146,504,876.8427,937,009.82-233,881,458.69-220,713,421.9
四、汇率变动对现金及现金等价物的影响-45,147,841.6-24,957,288.44-24,409,916.74-2,910,406.58
五、现金及现金等价物净增加额-961,621,729.59-744,502,980.54125,410,592.91-691,963,334.11
  加:期初现金及现金等价物余额1,635,685,891.791,635,685,891.791,510,275,298.881,510,275,298.88
  期末现金及现金等价物余额674,064,162.2891,182,911.251,635,685,891.79818,311,964.77
补充资料:
  净利润-232,060,997.06--597,405,207.55-
  资产减值准备13,558,090.52-199,366,343.14-
  固定资产和投资性房地产折旧51,653,529.68-99,727,986.03-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧51,653,529.68-99,727,986.03-
  无形资产摊销30,601,223.88-79,416,852.51-
  长期待摊费用摊销11,116,752.02-23,611,801.12-
  处置固定资产、无形资产和其他长期资产的损失-1,121,234.68--1,748,605.93-
  固定资产报废损失8,417.02-80,190.48-
  公允价值变动损失-1,245,811.82-1,596,613.77-
  财务费用82,609,804.8-14,961,338.09-
  投资损失-11,913,758.29--8,681,541.5-
  递延所得税27,705,748.38-12,161,015.42-
  其中:递延所得税资产减少27,729,824.05-12,350,615.94-
    递延所得税负债增加-24,075.67--189,600.52-
  存货的减少4,521,863.89--26,628,553.52-
  经营性应收项目的减少20,883,194.52--71,207,168.47-
  经营性应付项目的增加-49,873,445.92-56,400,578-
  其他306,479.97---
  现金的期末余额674,064,162.2-1,635,685,891.79-
  减:现金的期初余额1,635,685,891.79-1,510,275,298.88-
  现金及现金等价物的净增加额-961,621,729.59-125,410,592.91-
公告日期2026-08-292026-04-292026-04-292025-10-31
审计意见(境内)标准无保留意见
TOP↑